| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Emily C Amador, Jendayi L Olabisi, Elizabeth A Cunningha. Schizophrenia With Decompensation on Clozapine With Pramipexole. The primary care companion for CNS disorders. vol 21. issue 6. 2020-08-18. PMID:31877244. |
schizophrenia with decompensation on clozapine with pramipexole. |
2020-08-18 |
2023-08-13 |
Not clear |
| Elias Wagner, Thomas Wobrock, Birgit Kunze, Berthold Langguth, Michael Landgrebe, Peter Eichhammer, Elmar Frank, Joachim Cordes, Wolfgang Wölwer, Georg Winterer, Wolfgang Gaebel, Göran Hajak, Christian Ohmann, Pablo E Verde, Marcella Rietschel, Raees Ahmed, William G Honer, Dan Siskind, Berend Malchow, Wolfgang Strube, Thomas Schneider-Axmann, Peter Falkai, Alkomiet Hasa. Efficacy of high-frequency repetitive transcranial magnetic stimulation in schizophrenia patients with treatment-resistant negative symptoms treated with clozapine. Schizophrenia research. vol 208. 2020-08-17. PMID:30704862. |
efficacy of high-frequency repetitive transcranial magnetic stimulation in schizophrenia patients with treatment-resistant negative symptoms treated with clozapine. |
2020-08-17 |
2023-08-13 |
Not clear |
| Katherine Beck, Robert McCutcheon, Lucy Stephenson, Marcela Schilderman, Natasha Patel, Rosalind Ramsay, Oliver D Howe. Prevalence of treatment-resistant psychoses in the community: A naturalistic study. Journal of psychopharmacology (Oxford, England). vol 33. issue 10. 2020-08-17. PMID:31241396. |
however, the rate of treatment resistance among outpatients with schizophrenia or other psychoses, and the rate of use of clozapine among them, is not known. |
2020-08-17 |
2023-08-13 |
Not clear |
| Parnian Pardis, Gary Remington, Roshni Panda, Milan Lemez, Ofer Agi. Clozapine and tardive dyskinesia in patients with schizophrenia: A systematic review. Journal of psychopharmacology (Oxford, England). vol 33. issue 10. 2020-08-17. PMID:31347436. |
clozapine and tardive dyskinesia in patients with schizophrenia: a systematic review. |
2020-08-17 |
2023-08-13 |
Not clear |
| Seoyoung Kim, Wi Hoon Jung, Oliver D Howes, Mattia Veronese, Federico E Turkheimer, Yun-Sang Lee, Jae Sung Lee, Euitae Kim, Jun Soo Kwo. Frontostriatal functional connectivity and striatal dopamine synthesis capacity in schizophrenia in terms of antipsychotic responsiveness: an [ Psychological medicine. vol 49. issue 15. 2020-08-05. PMID:30460891. |
thus, the aim of this study was to investigate the relationship between frontostriatal fc and striatal dopamine synthesis capacity in patients with schizophrenia who had responded to first-line antipsychotic drug compared with those who had failed but responded to clozapine. |
2020-08-05 |
2023-08-13 |
Not clear |
| Jose de Leon, Can-Jun Ruan, Georgios Schoretsanitis, Carlos De Las Cueva. A Rational Use of Clozapine Based on Adverse Drug Reactions, Pharmacokinetics, and Clinical Pharmacopsychology. Psychotherapy and psychosomatics. vol 89. issue 4. 2020-07-17. PMID:32289791. |
using richardson and davidson's model and the sciences of pharmacokinetics and clinical pharmacopsychology, this article reviewed the: (1) poor life expectancy associated with treatment-resistant schizophrenia (trs), which may be improved in patients who adhere to clozapine; (2) findings that clozapine is the best treatment for trs (according to efficacy, effectiveness and well-being); and (3) potential for clozapine to cause vulnerabilities, including potentially lethal adverse drug reactions such as agranulocytosis, pneumonia, and myocarditis. |
2020-07-17 |
2023-08-13 |
Not clear |
| N Bouaziz, H Ben Rejeb, S Ateb, T Fourati, F Chammas, D Baha, R Rosetti, K Kalalou, G Saba, R Benadhira, D Janue. [Thoughts on a favourable evolution of a COVID-19 in a patient with resistant schizophrenia and on a combination of clozapine and paliperidone palmitate]. L'Encephale. vol 46. issue 3S. 2020-07-17. PMID:32475694. |
[thoughts on a favourable evolution of a covid-19 in a patient with resistant schizophrenia and on a combination of clozapine and paliperidone palmitate]. |
2020-07-17 |
2023-08-13 |
Not clear |
| Shih-Yu Chen, Gopi Ravindran, Qichen Zhang, Steve Kisely, Dan Siskin. Treatment Strategies for Clozapine-Induced Sialorrhea: A Systematic Review and Meta-analysis. CNS drugs. vol 33. issue 3. 2020-07-02. PMID:30758782. |
clozapine is the most effective medication for treatment-refractory schizophrenia. |
2020-07-02 |
2023-08-13 |
Not clear |
| Raphael J Braga, Majnu John, Nina R Schooler, Samuel H Bailine, Chitra Malur, Alan Mendelowitz, Georgios Petride. Continuation Electroconvulsive Therapy for Patients With Clozapine-Resistant Schizophrenia: A Pilot Study. The journal of ECT. vol 35. issue 3. 2020-06-23. PMID:30973454. |
the aim of the current study is to evaluate the efficacy of continuation ect for patients who showed response to the combination of acute ect and clozapine for treatment-resistant schizophrenia. |
2020-06-23 |
2023-08-13 |
Not clear |
| P A McArdle, V De Mel, V DeMonte, K Winckel, V Gore-Jones, S Foley, N Korman, S Parker, F Dark, D Siskin. An investigation into the relationship between clozapine treatment and cognitive performance in patients with treatment resistant schizophrenia. Schizophrenia research. vol 206. 2020-06-17. PMID:30527271. |
an investigation into the relationship between clozapine treatment and cognitive performance in patients with treatment resistant schizophrenia. |
2020-06-17 |
2023-08-13 |
Not clear |
| Yvonne van der Zalm, Fabian Termorshuizen, Iris E Sommer, Jean-Paul Selte. Use of cardiovascular and antidiabetic drugs before and after starting with clozapine versus other antipsychotic drugs: a Dutch database study. International clinical psychopharmacology. vol 35. issue 1. 2020-06-08. PMID:31714320. |
reports of decreased mortality among patients with schizophrenia who use clozapine may be biased if clozapine is prescribed to relatively healthy patients and if intensive monitoring during its use prevents (under-treatment of) somatic disorder. |
2020-06-08 |
2023-08-13 |
Not clear |
| Rajendra P Shukla, Remi Cazelles, Deanna L Kelly, Hadar Ben-Yoa. A reduced-graphene oxide-modified microelectrode for a repeatable detection of antipsychotic clozapine using microliters-volumes of whole blood. Talanta. vol 209. 2020-06-08. PMID:31892051. |
antipsychotic clozapine is the most effective medication currently available for schizophrenia. |
2020-06-08 |
2023-08-13 |
Not clear |
| Anthony P Morrison, Melissa Pyle, Andrew Gumley, Matthias Schwannauer, Douglas Turkington, Graeme MacLennan, John Norrie, Jemma Hudson, Samantha Bowe, Paul French, Paul Hutton, Rory Byrne, Suzy Syrett, Robert Dudley, Hamish J McLeod, Helen Griffiths, Thomas Re Barnes, Linda Davies, Gemma Shields, Deborah Buck, Sarah Tully, David Kingdo. Cognitive-behavioural therapy for clozapine-resistant schizophrenia: the FOCUS RCT. Health technology assessment (Winchester, England). vol 23. issue 7. 2020-06-04. PMID:30806619. |
clozapine (clozaril, mylan products ltd) is a first-choice treatment for people with schizophrenia who have a poor response to standard antipsychotic medication. |
2020-06-04 |
2023-08-13 |
Not clear |
| Anthony P Morrison, Melissa Pyle, Andrew Gumley, Matthias Schwannauer, Douglas Turkington, Graeme MacLennan, John Norrie, Jemma Hudson, Samantha Bowe, Paul French, Paul Hutton, Rory Byrne, Suzy Syrett, Robert Dudley, Hamish J McLeod, Helen Griffiths, Thomas Re Barnes, Linda Davies, Gemma Shields, Deborah Buck, Sarah Tully, David Kingdo. Cognitive-behavioural therapy for clozapine-resistant schizophrenia: the FOCUS RCT. Health technology assessment (Winchester, England). vol 23. issue 7. 2020-06-04. PMID:30806619. |
however, a significant number of patients who trial clozapine have an inadequate response and experience persistent symptoms, called clozapine-resistant schizophrenia (crs). |
2020-06-04 |
2023-08-13 |
Not clear |
| Syed Suhail Andrabi, Shruti Vishnoi, Riya Madan, Neha Bhardwaj, Heena Tabassum, Mohd Akram, Suhel Parve. Clozapine Improves Behavioral and Biochemical Outcomes in a MK-801-Induced Mouse Model of Schizophrenia. Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer. vol 39. issue 1. 2020-06-03. PMID:32479008. |
clozapine improves behavioral and biochemical outcomes in a mk-801-induced mouse model of schizophrenia. |
2020-06-03 |
2023-08-13 |
mouse |
| Syed Suhail Andrabi, Shruti Vishnoi, Riya Madan, Neha Bhardwaj, Heena Tabassum, Mohd Akram, Suhel Parve. Clozapine Improves Behavioral and Biochemical Outcomes in a MK-801-Induced Mouse Model of Schizophrenia. Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer. vol 39. issue 1. 2020-06-03. PMID:32479008. |
these findings show that clozapine possesses the potential to augment cognition in diseases such as schizophrenia. |
2020-06-03 |
2023-08-13 |
mouse |
| Jad Kesserwani, Giouliana Kadra, Johnny Downs, Hitesh Shetty, James H MacCabe, David Taylor, Robert Stewart, Chin-Kuo Chang, Richard D Haye. Risk of readmission in patients with schizophrenia and schizoaffective disorder newly prescribed clozapine. Journal of psychopharmacology (Oxford, England). vol 33. issue 4. 2020-06-01. PMID:30616489. |
risk of readmission in patients with schizophrenia and schizoaffective disorder newly prescribed clozapine. |
2020-06-01 |
2023-08-13 |
Not clear |
| Jad Kesserwani, Giouliana Kadra, Johnny Downs, Hitesh Shetty, James H MacCabe, David Taylor, Robert Stewart, Chin-Kuo Chang, Richard D Haye. Risk of readmission in patients with schizophrenia and schizoaffective disorder newly prescribed clozapine. Journal of psychopharmacology (Oxford, England). vol 33. issue 4. 2020-06-01. PMID:30616489. |
our objective was to investigate the association between clozapine prescribed at discharge, following an inpatient episode, and risk of readmission into secondary mental health services in patients with schizophrenia and schizoaffective disorder, controlling extensively for confounding variables. |
2020-06-01 |
2023-08-13 |
Not clear |
| Amir Krivoy, Dan Joyce, Derek Tracy, Fiona Gaughran, James MacCabe, John Lally, Eromona Whiskey, S Neil Sarkar, Sukhwinder S Shergil. Real-World Outcomes in the Management of Refractory Psychosis. The Journal of clinical psychiatry. vol 80. issue 5. 2020-05-22. PMID:31556974. |
clozapine is the only medication approved for those patients with schizophrenia who do not achieve a clinical response to standard antipsychotic treatment, yet it is still underused. |
2020-05-22 |
2023-08-13 |
Not clear |
| Mayela Vaquero-Baez, Araceli Díaz-Ruíz, Luis Tristán-López, Carlos Aviña-Cervantes, Carlos Torner, Jesús Ramírez-Bermúdez, Sergio Montes, Camilo Río. Clozapine and desmethylclozapine: correlation with neutrophils and leucocytes counting in Mexican patients with schizophrenia. BMC psychiatry. vol 19. issue 1. 2020-05-20. PMID:31597566. |
clozapine and desmethylclozapine: correlation with neutrophils and leucocytes counting in mexican patients with schizophrenia. |
2020-05-20 |
2023-08-13 |
Not clear |